Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

RNA in disease

Project description

Furthering RNA biology research

A new promising influential area in modern biology and medicine is ribonucleic acid (RNA) biology. It has revolutionised molecular biology and will have profound implication for future therapies. The Instituto de Medicina Molecular João Lobo Antunes (iMM) in Portugal will gain the support it needs to achieve scientific excellence and promote research in RNA biology. The EU-funded project RiboMed will help iMM establish a strategic collaboration via twinning with partners from already well recognised communities working on RNA biology in connection with neuroscience, immunology and infection. They will organise staff exchanges, experts’ visits, common works in laboratories, thematic courses, mentoring, conferences and work towards new findings and targets.

Objective

The Instituto de Medicina Molecular João Lobo Antunes (iMM) ranks among the top research institutions in Portugal. However, the institute faces constraints related to reduced availability of national research funding and access to cutting-edge resources and scientific infrastructure. This twinning proposal (RiboMed) was set on the strategic vision of iMM to boost its recently enlarged community of young RNA researchers. In fact, while iMM has well-established communities working on neuroscience, immunology and infection, RNA biology is only now starting to expand as we recognize its centrality in human health. Our strategy includes: 1) Promoting scientific excellence through the implementation of joint research projects between iMM and the twinning partners. We will strengthen existing interactions and promote new collaborations through short-term staff exchanges, expert visits and joint lab retreats; 2) Nurturing a community of self-challenging and ambitious students and early-stage researchers at iMM by ensuring their early integration in international training and mentoring networks, facilitating conference attendance, and organizing summer schools, thematic courses and on-site training; 3) Raising international awareness of iMM through mobility of researchers, targeted dissemination and communication activities, and on-site organization of workshops and a major international conference; 4) Consolidating the innovation and entrepreneurship ecosystem at iMM through translation of basic findings into potential novel RNA biomarkers, RNA-based diagnostic assays and RNA therapeutic targets. We believe RiboMed is exceptionally timely, as it will allow the recently settled young RNA researchers to thrive at iMM. This, in turn, will place the institute in Lisbon within the core of European laboratories that are carrying on frontier research on how transcription and RNA processing shape and define the complexity of human disease.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CSA - Coordination and support action

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-WIDESPREAD-2018-2020

See all projects funded under this call

Coordinator

FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 424 750,00
Address
AVENIDA PROFESSOR EGAS MONIZ
1649-035 LISBOA
Portugal

See on map

Activity type
Research Organisations
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 424 750,00

Participants (3)

My booklet 0 0